Navigation Links
Low levels of oxgen, nitric oxide worsen sickle cell disease
Date:3/20/2014

Low levels of both oxygen and the powerful blood vessel dilator nitric oxide appear to have an unfortunate synergy for patients with sickle cell disease, researchers report.

Their studies indicate that the two conditions common in sickle cell disease, dramatically increase red blood cells' adhesion to the lining of blood vessels walls and the debilitating pain crises that can result.

The good news is that restoring normal levels of nitric oxide can substantially reduce red blood cell adhesion, said Dr. Tohru Ikuta, a molecular hematologist at the Medical College of Georgia at Georgia Regents University. Ikuta and Dr. C. Alvin Head, former Chairman of MCG's Department of Anesthesiology and Perioperative Medicine, are co-corresponding authors of the study in the journal Blood.

The study also points to a potentially new therapeutic target, the self-adhesion molecule P-selectin, which the researchers found played a central role in increased red blood cell adhesion. Low levels of oxygen and nitric oxide both increase expression of P-selectin.

Hypoxia, or low oxygen levels, can strike anyone in the face of, for instance, the flu, a bad cold, strenuous exercise or exposure to high altitudes. Additionally, sickle cell patients can have chronic problems with oxygen delivery.

Oxygen is carried in hemoglobin, which travels the bloodstream to its target tissue inside typically flexible, oval-shaped red blood cells. The sickled shape of the hemoglobin in sickle cell disease can impede the journey and often results in oddly shaped, fragile red blood cells as well, said Ikuta. These red blood cells can spill their contents into the bloodstream, where oxygen readily binds with the nitric oxide and patients quickly find themselves with insufficient levels of both.

To understand the relationship between low levels of oxygen and nitric oxide, researchers infused sickled red blood cells into mice incapable of producing nitric oxide. The cells immediately began sticking to blood vessel walls, while normal mice were unaffected. In the face of low oxygen levels, or hypoxia, cell adhesion increased significantly in the nitric oxide-deficient mice.

"It's a synergy," Ikuta said. "This shows that hypoxia and low nitric oxide levels work together in a bad way for sickle cell patients."

When they restored normal nitric oxide levels by having mice breathe in the short-lived gas as patients have done in clinical trials cell adhesion did not increase when oxygen levels decreased. Interestingly, there was no additional benefit from increasing nitric oxide levels beyond normal. Rather, restoring normal nitric oxide levels appears the most efficient, effective way to reduce red blood cell adhesion, the researchers write.

Clinical trials of nitric oxide therapy to ease pain in sickle cell patients have yielded conflicting results, with some patients reporting increased pain. The new findings and the fact that patients with sickle cell disease have significant variability in their nitric oxide levels even during a pain crisis likely explains why, Ikuta said.

Nitric oxide therapy likely would benefit only patients with intermittent or chronically low levels, he said. "The answer is that some patients may not need this. And, our studies indicate that there is no therapeutic benefit to increasing levels beyond physiologic levels."

Nitric oxide blood levels can be readily measured, he noted, and are more likely to drop in every patient during a pain crisis.


'/>"/>
Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University
Source:Eurekalert  

Related biology news :

1. Study suggests higher levels of omega-3 in diet are associated with better sleep
2. New probes from Scripps research quantify folded and misfolded protein levels in cells
3. High pollutant levels in Guánica Bay represent serious toxic threat to corals
4. Researchers use genetic signals affecting lipid levels to probe heart disease risk
5. Low vitamin D levels during pregnancy may increase risk of severe preeclampsia
6. Higher vitamin D levels associated with better cognition and mood in PD patients
7. High levels of maternal care has life-long impact on vulnerability to stress
8. Oxygen levels increase and decrease the effectiveness of anti-inflammatory therapies
9. Low levels of blood calcium in dairy cows may affect cow health and productivity, MU study finds
10. Despite menu changes, calorie and sodium levels in chain restaurant entrees remain the same overall
11. Safe levels of environmental pollution may have long-term health consequences
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Low levels of oxgen, nitric oxide worsen sickle cell disease
(Date:5/14/2020)... NEW CENTURY, Kan. (PRWEB) , ... May 13, ... ... the North American launch of Bonlacta™, its latest enzyme for the lactose-free dairy ... production of a wide range of lactose-free dairy products at competitive costs across ...
(Date:5/1/2020)... ... April 30, 2020 , ... USARAD Holdings Inc., the leading ... VC firms announces an official launch of CareDoctors.com. In an effort to help ... experience by offering live video consultations with board certified physicians in all specialties ...
(Date:4/30/2020)... ... April 28, 2020 , ... Ever a responsive and ... providing timely and critical information to life science organizations as they navigate the ... concerns. , “Providing the most up-to-date actionable guidance and information has been a ...
Breaking Biology News(10 mins):
(Date:5/15/2020)... ... May 15, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage biotechnology ... as Executive Chairman. Mr. Ganz will continue to lead Sentien’s Board of Directors, ... closely with CEO Brian Miller and Sentien’s management team. , Mr. Ganz ...
(Date:5/14/2020)... ... , ... Early stages of drug discovery often depend on ... the drug’s mechanism of action (MOA). Gene expression profiling technologies like RNA sequencing ... molecular pathways. This information can complement phenotypic readouts and can be used to ...
(Date:5/5/2020)... , ... May 05, 2020 , ... ... company, announced today the launch of its iGlucose® LTE Cat-M Cellular ... solution utilizes LTE Cat-M1 technology, the industry’s newest and broadest cellular connectivity available, ...
(Date:4/22/2020)... ... April 20, 2020 , ... Global molecular diagnostics ... that Omixon’s founder and chairman Dr. Attila Berces returns as CEO. Outgoing CEO ... since 2014 before stepping into the CEO role in 2017. , In ...
Breaking Biology Technology: